# Health Innovations

> Health Innovations is a VC fund in Utrecht backing Health Care, Medical and Medical Device. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Utrecht, The Netherlands
- Total investments: 9
- Last investment: Sep 2025
- Lead investor: 33%
- Last fund: Jan 2018
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/health-innovations
- Website: https://www.healthinnovations.nl/en/

Health Innovations is a VC fund in Utrecht focused on Health Care and Medical. Health Innovations invests in young companies that make healthcare better and more affordable. They focus on innovative care concepts, eHealth, medical technology, Digital Health and Health Services. The market is central to their process. How companies can contribute to improving healthcare processes: prevention, diagnosis, treatment andmonitoring. They invest in the Seed and Growth stage, and their investment must contribute to value creation for healthcare, the entrepreneurs and the shareholders. They play an active role as a shareholder by deploying their knowledge, experience and network but do not take on the role of the entrepreneur.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 6 | 67% |
| Medical | 4 | 44% |
| Medical Device | 4 | 44% |
| Hospital | 2 | 22% |
| Therapeutics | 2 | 22% |

19 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 33% |
| Venture - Series Unknown | 2 | 22% |
| Series A | 1 | 11% |
| Series C | 1 | 11% |
| Series D | 1 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| The Netherlands | 5 | 56% |
| United States | 1 | 11% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aiosyn | Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancerand CKD drug development studies for biopharma. | $2.8M | Seed | Sep 09, 2025 |  |
| ViCentra | ViCentra, they like to keep things simple.ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things.Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customerexperiences.From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people. | $85M | Series D | Sep 03, 2025 |  |
| Aiosyn | Aiosyn uses artificial intelligence to develop pathology algorithms to improve the precision of diagnostics in cancer and chronic kidney diseases. The company uses a modular SaaS model to integrate its algorithms with existing pathology workflows. At the same time it leverages its algorithms and AI capabilities to improve the efficiency of cancerand CKD drug development studies for biopharma. | $2.1M | Seed | Dec 21, 2022 |  |
| Prolira makers of DeltaScan® | Prolira is committed to enabling early and effective treatment of acute encephalopathy and delirium. Every year, 20 million patients are at risk of acute brain failure in EU and US hospitals, which leads to long-term cognitive impairment, extended hospital stays, and increased healthcare costs.Prolira’s DeltaScan® Brain State Monitor is theworld’s first EEG bedside device with a validated proprietary algorithm to support clinicians in their quest to optimize patient recovery. | $4.4M | Venture - Series Unknown | Feb 01, 2022 |  |
| Bilihome B.V. | Bilihome aims to provide an ordinary-looking romper or vest for newborns, which enables natural care and free bonding during jaundice therapy in the first week of life. The embedded smart wearables and the miniaturized system simplify the logistics and encourage care outside the hospital. |  | Seed | Jan 23, 2022 |  |
| ViCentra | ViCentra, they like to keep things simple.ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things.Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customerexperiences.From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people. | $73.7M | Series C | Dec 16, 2021 |  |
| ViCentra | ViCentra, they like to keep things simple.ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things.Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customerexperiences.From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people. | $11.3M | Venture - Series Unknown | Jul 08, 2020 |  |
| Shleep | Shleep is an app-based sleep coaching platform in the Health Tech sector, that enables people and organizations reap the benefits of better sleep. A unique algorithm ensures that users receive tailormade sleep advice based on their specific situation. Though the platform revolves around the app, Shleep also offers online sleep assessments, liveworkshops, online webinars, and personal coaching. Several large companies have agreed to be our pilot customers and test our product and services. | $1.5M | Seed | Aug 20, 2019 |  |
| DEARhealth | DEARhealth offers Value-based Health Care solutions for medical providers and health insurers, which significantly improve the health outcomes and experience of chronically ill patients while dramatically reducing costs. | $6.8M | Series A | Jul 17, 2019 |  |

9 of 9 investments shown.

## Co-investors
- [OostNL](https://shizune.co/investors/profile/oostnl) — VC Fund, 4 deals together
- [EQT Life Sciences](https://shizune.co/investors/profile/life-sciences-partners) — VC Fund, 3 deals together
- [Inkef](https://shizune.co/investors/profile/inkef-capital) — VC Fund, 2 deals together
- [Invest-NL](https://shizune.co/investors/profile/invest-nl) — VC Fund, 2 deals together
- [LUMO labs](https://shizune.co/investors/profile/lumo-labs) — VC Fund, 2 deals together
- Partners in Equity — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Health Innovations invest in?

Health Innovations invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Venture - Series Unknown stage. Most of the 9 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Health Innovations last invest?

The most recent investment recorded for Health Innovations closed in Sep 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co